Nektar Therapeutics
The latest news about Nektar Therapeutics: headlines, AI summaries and the full story from every source.
- Nektar Therapeutics Investors Have Deadline to Join Securities Fraud Lawsuit
- Class Action Lawsuit Filed Against Nektar Therapeutics Over Alleged Misleading Statements
- Nektar Therapeutics Reports Positive Clinical Trial Results for Hair-Loss Drug
- Nektar Therapeutics Securities Fraud Lawsuit Allows Investors to Join Class Action
- Nektar Therapeutics Reports Positive Phase 2b Trial Results for Hair-Loss Drug, Driving Stock Higher
- Pomerantz Law Firm Files Class Action Against Nektar Therapeutics and Officers